Dr. Rebecca E. Oberley-Deegan is a Professor at the UNMC Department of Biochemistry and Molecular Biology, Omaha, NE, USA. She holds a B.A. from Grinnell College (1999) and a PhD from the University of Iowa (2004). She did postdoctoral training at National Jewish Health (Denver, CO, USA). Dr. Oberley-Deegan’s laboratory focuses on reducing side effects associated with cancer therapy. The main goal is to reduce radiation and chemotherapy-induced toxicity to normal tissues while not protecting the tumor cells from being killed by these therapies.